These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11434173)

  • 1. [Epidemiology of HBV infections and possibilities for therapeutic actions in children and adolescents with end-stage renal failure treated with dialysis].
    Zwolińska D; Inglot M; Makulska I; Gładysz A; Szprynger K; Szczepańska M; Pietrzyk J; Zachwieja K; Zurowska A; Zachwieja J; Rajkowski T; Jobs K; Latoszyńska J; Jander A
    Pol Merkur Lekarski; 2001 Apr; 10(58):267-70. PubMed ID: 11434173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HBV infection in patients with end-stage renal disease.
    Fabrizi F; Bunnapradist S; Martin P
    Semin Liver Dis; 2004; 24 Suppl 1():63-70. PubMed ID: 15192803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis and HIV infection during haemodialysis.
    Saha D; Agarwal SK
    J Indian Med Assoc; 2001 Apr; 99(4):194-9, 203, 213. PubMed ID: 11666025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How many patients with chronic viral hepatitis qualify for interferon therapy? Prospective analysis of university ambulatory care].
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Med Klin (Munich); 1993 Sep; 88(9):511-5, 562. PubMed ID: 8232088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National surveillance of dialysis-associated diseases in the United States, 2002.
    Finelli L; Miller JT; Tokars JI; Alter MJ; Arduino MJ
    Semin Dial; 2005; 18(1):52-61. PubMed ID: 15663766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
    Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
    Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Infections with hepatitis B virus in hemodialysis units of Wielkopolska].
    Grzegorzewska AE; Kurzawska-Firlej D; Swiderski A; de Mezer-Dambek M; Frankiewicz D; Zaremba-Drobnik D; Banachowicz W; Dumanowska-Zmuda A; Ratajewski W; Niepolski L; Krawczyk R; Sobolewski J; Pulchny J; Molenda J; Wojciechowski J; Mikstacki Z; Zachwieja J
    Przegl Epidemiol; 2008; 62(1):29-37. PubMed ID: 18536222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
    Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention and treatment of hepatitis B in patients on hemodialysis and vaccination of hemodialysis health personnel against hepatitis B].
    Kes P; Slavicek J; Janković N
    Acta Med Croatica; 2005; 59(5):479-82. PubMed ID: 16381247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
    Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HCV and HBV prevalence in hemodialyzed pediatric patients. Multicenter study].
    Cañero-Velasco MC; Mutti JE; Gonzalez JE; Alonso A; Otegui L; Adragna M; Antonuccio M; Laso M; Montenegro M; Repetto L; Brandi M; Canepa J; Baimberg E
    Acta Gastroenterol Latinoam; 1998; 28(3):265-8. PubMed ID: 9773156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants.
    Koltan S; Koltan A; Wysocki M; Debski R; Styczynski J
    J Hosp Infect; 2005 May; 60(1):73-7. PubMed ID: 15823661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus infection and the dialysis patient.
    Fabrizi F; Messa P; Martin P
    Semin Dial; 2008; 21(5):440-6. PubMed ID: 18397202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B in children.
    Broderick AL; Jonas MM
    Semin Liver Dis; 2003 Feb; 23(1):59-68. PubMed ID: 12616451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B and C in dialysis units in Iran: changing the epidemiology.
    Alavian SM; Bagheri-Lankarani K; Mahdavi-Mazdeh M; Nourozi S
    Hemodial Int; 2008 Jul; 12(3):378-82. PubMed ID: 18638096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamivudine treatment for chronic hepatitis B infection in children unresponsive to interferon.
    Hartman C; Berkowitz D; Shouval D; Eshach-Adiv O; Hino B; Rimon N; Satinger I; Kra-Oz T; Daudi N; Shamir R
    Pediatr Infect Dis J; 2003 Mar; 22(3):224-9. PubMed ID: 12634582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interferon therapy in cildren with chronic hepatitis and chronic renal failure treated with dialysis].
    Szczepańska M; Szprynger K; Morawiec-Knysak A; Schneiberg B; Augustyn-Iwachów T; Dyduch A
    Pol Merkur Lekarski; 2000 Sep; 9 Suppl 1():33-6. PubMed ID: 11081342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.